12/1
07:00 am
bcax
Bicara Therapeutics Announces Publication of an Abstract with Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab in 1L HPV-negative R/M HNSCC at ESMO Asia 2025
Medium
Report
Bicara Therapeutics Announces Publication of an Abstract with Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab in 1L HPV-negative R/M HNSCC at ESMO Asia 2025
11/11
09:44 am
bcax
Bicara Therapeutics (NASDAQ:BCAX) had its price target raised by analysts at Wells Fargo & Company from $8.00 to $11.00. They now have an "equal weight" rating on the stock.
Medium
Report
Bicara Therapeutics (NASDAQ:BCAX) had its price target raised by analysts at Wells Fargo & Company from $8.00 to $11.00. They now have an "equal weight" rating on the stock.
11/10
09:04 am
bcax
Bicara Therapeutics (NASDAQ:BCAX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $30.00 price target on the stock.
Medium
Report
Bicara Therapeutics (NASDAQ:BCAX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $30.00 price target on the stock.
11/10
09:03 am
bcax
Bicara Therapeutics GAAP EPS of -$0.67 [Seeking Alpha]
Medium
Report
Bicara Therapeutics GAAP EPS of -$0.67 [Seeking Alpha]
11/10
07:41 am
bcax
Bicara Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Bicara Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
11/10
07:30 am
bcax
Bicara Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Medium
Report
Bicara Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
10/27
08:30 am
bcax
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
Low
Report
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
10/27
08:30 am
bcax
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
Low
Report
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
10/14
09:40 am
bcax
How Investors May Respond To Bicara Therapeutics (BCAX) FDA Breakthrough Therapy Nod for Lead Immunotherapy [Yahoo! Finance]
Low
Report
How Investors May Respond To Bicara Therapeutics (BCAX) FDA Breakthrough Therapy Nod for Lead Immunotherapy [Yahoo! Finance]
10/13
07:39 am
bcax
Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC [Yahoo! Finance]
Low
Report
Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC [Yahoo! Finance]
10/13
07:30 am
bcax
Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC
Low
Report
Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC
10/3
05:21 pm
bcax
Bicara Therapeutics files $400M mixed securities shelf [Seeking Alpha]
Medium
Report
Bicara Therapeutics files $400M mixed securities shelf [Seeking Alpha]